Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Multicenter Study of Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

NCT01610180 is registered in ClinicalTrials.gov with Fondazione Progetto Ematologia as lead sponsor.

NCT NCT01610180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01610180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Multicenter Study of Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
Lead sponsor
Fondazione Progetto Ematologia
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2012
Completion date
June 30, 2018
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune thrombocytopenia, autoimmune thrombocytopenic purpura, chronic lymphocytic leukemia, non hodgkin's lymphoma, purpura, thrombocytopenic, idiopathic